LODEKSA MEDICAL LEECHES - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 26,082 | 34,337 | 58,051 | 94,732 | 66,511 | 91,665 | 119,309 | 218,779 |
| Profit before tax | 4,752 | - | - | - | - | - | - | - |
| Net profit | 4,514 | -9,159 | 16,402 | 25,720 | 760 | 31,818 | 49,122 | 122,305 |
| Equity | 6,128 | -3,031 | 6,500 | 43,091 | 43,851 | 75,669 | 74,733 | 154,685 |
| Liabilities | 5,579 | 6,961 | 12,444 | 35,729 | 42,761 | 53,429 | 54,070 | 64,753 |
| Non-current assets | 0 | 0 | 1,905 | 62,267 | 52,850 | 48,156 | 64,124 | 72,467 |
| Current assets | 11,707 | 3,930 | 17,039 | 15,775 | 31,905 | 79,734 | 63,095 | 145,522 |
| Total assets | 11,707 | 3,930 | 18,944 | 78,042 | 84,755 | 127,890 | 127,219 | 217,989 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 11,316 | 25,386 | 24,345 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18139.2% | +31.7% | +69.1% | +63.2% | -29.8% | +37.8% | +30.2% | +83.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 38.6% | -233.1% | 86.6% | 33.0% | 0.9% | 24.9% | 38.6% | 56.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 73.7% | - | 252.3% | 59.7% | 1.7% | 42.0% | 65.7% | 79.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.3% | -26.7% | 28.3% | 27.2% | 1.1% | 34.7% | 41.2% | 55.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.2% | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | - | 1.9 | 0.8 | 1.0 | 0.7 | 0.7 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,781 | 7,774 | 13,144 | 23,200 | 22,170 | 30,555 | 39,770 | 72,926 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
LODEKSA MEDICAL LEECHES - Social security debts
The company had no debts to Sodra
LODEKSA MEDICAL LEECHES - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-18 | 2024-12-27 | 0.41 |
| 2024-12-17 | 2024-12-17 | 1548.4 |
| 2024-12-16 | 2024-12-16 | 1547.99 |
| 2024-12-14 | 2024-12-15 | 1530.76 |
| 2024-11-22 | 2024-11-23 | 7.21 |
| 2024-11-20 | 2024-11-21 | 160.64 |
| 2024-11-12 | 2024-11-19 | 149.82 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
LODEKSA MEDICAL LEECHES, UAB (code 304606856) is a Private Limited Liability Company engaged in freshwater aquaculture. In 2025, the company reported revenue of €218.8K and net profit of €122.3K, with a profit margin of 55.9%. Performance strengthened notably year on year: revenue increased by 83.4% from 2024, and over two years revenue rose by 138.7% from €91.7K in 2023. Net profit also expanded from €31.8K in 2023 to €49.1K in 2024 and €122.3K in 2025, indicating a clear upward profitability trend. The balance sheet remained well capitalised, with total assets of €218.0K, equity of €154.7K and liabilities of €64.8K in 2025. The equity ratio was 71.0% and debt-to-equity stood at 0.42, pointing to a conservative funding structure. Asset turnover was 1.00x, while return on equity reached 79.1% and return on assets 56.1%. Revenue per employee was €72.9K and profit per employee €40.8K, suggesting solid operating productivity.